administration (40 mg/kg) for 21 days or more and captopril administration was continued during behavioral tests. To identify the effect of captopril on behavior, mice were randomly assigned to the control, chronic restraint stress group (CRS) and CHC group (A). Mice in each group were divided into 2 groups and we performed different set of behavior tests in each subgroup. The behavior test including TST, FST, SP, LD, EPM, SI and rotarod were performed to assess behavior of mice associated with depression, anxiety and sociality. To assess captopril washout effect, regular drinking water without captopril was provided to mice after 21 days of captopril administration for following 7 days and TST and FST were performed within 1 weeks since captopril washout (B). To identify the effect of antidepressant on CHC-induced depressive-like behavior, imipramine (20 mg/kg) was administrated intraperitoneally once a day with captopril administration (Co-Imi) and depressive-like behavior of mice were assessed by TST and FST (C). In addition, imipramine at same dose was treated after captopril administration for 21 days (post-Imi) and depressive-like behavior of mice were assessed by same tools with Co-Imi (D).
